Candida auris: report of an outbreak

Enferm Infecc Microbiol Clin (Engl Ed). 2020 Jan:38 Suppl 1:39-44. doi: 10.1016/j.eimc.2020.02.007.
[Article in English, Spanish]

Abstract

Candida auris is an emerging multidrug-resistant yeast that causes serious invasive infections and outbreaks with high mortality. Controlling C. auris is a challenge in which laboratories, clinicians and public health agencies are needed to identify and treat infections and prevent transmission. This review describes the general aspects of the biology, diagnosis and treatment of C. auris infection, as well as the main recommendations recently published by expert groups. We also present our experience of the C. auris outbreak at the Consorcio Hospital General Universitario de Valencia from September 2017 to August 2019. A total of 203 patients were colonised and/or infected by C. auris. Thirty invasive infections (29 blood cultures and one case of meningitis) were diagnosed. In all, 32% cases of candidemia were caused by C. auris in 2018. All strains were resistant to fluconazole.

Keywords: Candida auris; Control; Emerging microorganisms; Microorganismo emergente; Multiresistance; Multirresistencia; Transmisión; Transmission.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / therapeutic use
  • Candida / drug effects
  • Candidiasis, Invasive / epidemiology*
  • Cross Infection* / drug therapy
  • Disease Outbreaks
  • Drug Resistance, Fungal
  • Humans
  • Spain / epidemiology

Substances

  • Antifungal Agents

Supplementary concepts

  • Candida auris infection